Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AFIB Acutus Medical	$0.00 -95.0%	$0.01	$0.00 ▼ $0.22	$3K	-0.34	33,561 shs	97,575 shs
CLPT ClearPoint Neuro	$11.76 -0.3%	$12.55	$5.39 ▼ $19.22	$329.16M	0.92	257,430 shs	375,007 shs
CTSO Cytosorbents	$1.05 +1.9%	$1.01	$0.71 ▼ $1.61	$65.74M	1.19	148,984 shs	72,903 shs
PROF Profound Medical	$5.99 -1.6%	$5.56	$3.90 ▼ $11.42	$180M	0.49	65,385 shs	7,278 shs
UFPT UFP Technologies	$243.12 +0.9%	$235.85	$178.26 ▼ $366.41	$1.87B	1.11	107,836 shs	126,341 shs

The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AFIB Acutus Medical	-95.00%	-95.00%	-95.65%	-99.74%	-99.67%
CLPT ClearPoint Neuro	-0.42%	-1.17%	-15.29%	+12.27%	+116.91%
CTSO Cytosorbents	-0.96%	-19.53%	-2.83%	+7.29%	+13.32%
PROF Profound Medical	+1.75%	+3.22%	+9.34%	+34.14%	-31.57%
UFPT UFP Technologies	-6.19%	-1.27%	+1.52%	+24.77%	-17.86%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AFIB Acutus Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CLPT ClearPoint Neuro	1.5342 of 5 stars	3.5	2.0	0.0	0.0	0.0	0.8	0.6
CTSO Cytosorbents	1.7493 of 5 stars	3.5	2.0	0.0	0.0	1.5	0.0	0.6
PROF Profound Medical	2.6574 of 5 stars	3.5	2.0	0.0	0.0	2.1	2.5	0.6
UFPT UFP Technologies	0.6222 of 5 stars	1.3	1.0	0.0	0.0	2.7	2.5	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AFIB Acutus Medical	0.00	N/A	N/A	N/A
CLPT ClearPoint Neuro	3.00	Buy	$25.00	112.59% Upside
CTSO Cytosorbents	3.00	Buy	$5.50	423.81% Upside
PROF Profound Medical	3.00	Buy	$11.50	91.99% Upside
UFPT UFP Technologies	2.50	Moderate Buy	$252.00	3.65% Upside

Current Analyst Ratings Breakdown

Latest PROF, CTSO, UFPT, AFIB, and CLPT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/25/2025	CTSO Cytosorbents	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$10.00
5/15/2025	CTSO Cytosorbents	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$10.00 ➝ $10.00
5/15/2025	CTSO Cytosorbents	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$1.00 ➝ $1.00
5/9/2025	PROF Profound Medical	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Moderate Buy
5/7/2025	UFPT UFP Technologies	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$252.00
5/2/2025	CTSO Cytosorbents	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$10.00 ➝ $10.00
4/23/2025	PROF Profound Medical	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$17.00 ➝ $11.00

(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AFIB Acutus Medical	$7.16M	0.00	N/A	N/A	($0.03) per share	0.00
CLPT ClearPoint Neuro	$31.39M	10.49	N/A	N/A	$0.92 per share	12.78
CTSO Cytosorbents	$35.33M	1.86	N/A	N/A	$0.20 per share	5.25
PROF Profound Medical	$10.68M	16.85	N/A	N/A	$2.01 per share	2.98
UFPT UFP Technologies	$547.56M	3.42	$10.44 per share	23.28	$44.66 per share	5.44

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AFIB Acutus Medical	-$81.66M	N/A	0.00	∞	N/A	-272.74%	-311.64%	-11.57%	N/A
CLPT ClearPoint Neuro	-$18.91M	-$0.76	N/A	N/A	N/A	-64.51%	-78.09%	-51.33%	8/6/2025 (Estimated)
CTSO Cytosorbents	-$20.72M	-$0.28	N/A	N/A	N/A	-41.77%	-105.04%	-29.18%	8/12/2025 (Estimated)
PROF Profound Medical	-$27.82M	-$1.22	N/A	N/A	N/A	-269.35%	-70.41%	-57.22%	8/6/2025 (Estimated)
UFPT UFP Technologies	$58.98M	$8.17	29.76	∞	N/A	11.59%	21.27%	12.24%	7/30/2025 (Estimated)

Latest PROF, CTSO, UFPT, AFIB, and CLPT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2025	Q2 2025	UFPT UFP Technologies	$2.29	N/A	N/A	N/A	$151.55 million	N/A
5/14/2025	Q1 2025	CTSO Cytosorbents	-$0.08	-$0.06	+$0.02	-$0.02	$9.01 million	$8.73 million
5/13/2025	Q1 2025	CLPT ClearPoint Neuro	-$0.15	-$0.22	-$0.07	-$0.22	$8.21 million	$8.49 million
5/8/2025	Q1 2025	PROF Profound Medical	-$0.29	-$0.36	-$0.07	-$0.36	$4.78 million	$2.62 million
5/6/2025	Q1 2025	UFPT UFP Technologies	$2.05	$2.47	+$0.42	$2.21	$139.93 million	$148.15 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AFIB Acutus Medical	N/A	N/A	N/A	N/A	N/A
CLPT ClearPoint Neuro	N/A	N/A	N/A	N/A	N/A
CTSO Cytosorbents	N/A	N/A	N/A	N/A	N/A
PROF Profound Medical	N/A	N/A	N/A	N/A	N/A
UFPT UFP Technologies	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AFIB Acutus Medical	N/A	1.85	1.57
CLPT ClearPoint Neuro	N/A	3.53	2.57
CTSO Cytosorbents	0.98	2.61	2.30
PROF Profound Medical	0.09	11.31	10.03
UFPT UFP Technologies	0.47	2.58	1.45

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AFIB Acutus Medical	56.91%
CLPT ClearPoint Neuro	30.08%
CTSO Cytosorbents	32.87%
PROF Profound Medical	47.86%
UFPT UFP Technologies	87.28%

Insider Ownership

Company	Insider Ownership
AFIB Acutus Medical	5.21%
CLPT ClearPoint Neuro	6.11%
CTSO Cytosorbents	7.30%
PROF Profound Medical	1.52%
UFPT UFP Technologies	4.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AFIB Acutus Medical	340	29.78 million	28.23 million	Optionable
CLPT ClearPoint Neuro	110	27.99 million	26.28 million	Optionable
CTSO Cytosorbents	220	62.61 million	58.48 million	Optionable
PROF Profound Medical	150	30.05 million	29.60 million	Optionable
UFPT UFP Technologies	4,335	7.71 million	7.37 million	Optionable

PROF, CTSO, UFPT, AFIB, and CLPT Headlines

Recent News About These Companies

UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the CJS Securities 25th Annual Summer Conference

July 8 at 8:00 AM | globenewswire.com

Calamos Advisors LLC Has $414,000 Position in UFP Technologies, Inc. (NASDAQ:UFPT)

July 7 at 4:57 AM | marketbeat.com

Allspring Global Investments Holdings LLC Acquires New Position in UFP Technologies, Inc. (NASDAQ:UFPT)

July 7 at 3:43 AM | marketbeat.com

Implied Volatility Surging for UFP Technologies Stock Options

June 30, 2025 | msn.com

5 Insightful Analyst Questions From UFP Technologies’s Q1 Earnings Call

June 27, 2025 | finance.yahoo.com

Bessemer Group Inc. Has $17.90 Million Stock Holdings in UFP Technologies, Inc. (NASDAQ:UFPT)

June 27, 2025 | marketbeat.com

UFPT UFP Technologies, Inc. - Seeking Alpha

June 24, 2025 | seekingalpha.com

Boston Trust Walden Corp Purchases 106,197 Shares of UFP Technologies, Inc. (NASDAQ:UFPT)

June 20, 2025 | marketbeat.com

UFP Technologies, Inc. (NASDAQ:UFPT) Shares Sold by Assenagon Asset Management S.A.

June 20, 2025 | marketbeat.com

UFP Technologies, Inc. (NASDAQ:UFPT) Stock Holdings Raised by SG Americas Securities LLC

June 20, 2025 | marketbeat.com

What Makes UFP Technologies (UFPT) a Prospective Bet?

June 19, 2025 | insidermonkey.com

Mountain Pacific Investment Advisers LLC Purchases 1,262 Shares of UFP Technologies, Inc. (NASDAQ:UFPT)

June 16, 2025 | marketbeat.com

Park Avenue Securities LLC Makes New $564,000 Investment in UFP Technologies, Inc. (NASDAQ:UFPT)

June 15, 2025 | marketbeat.com

UFP Technologies Highlights Strategic Focus on Medical Market

June 10, 2025 | tipranks.com

GAMMA Investing LLC Boosts Stock Holdings in UFP Technologies, Inc. (NASDAQ:UFPT)

June 10, 2025 | marketbeat.com

Bridge City Capital LLC Grows Stake in UFP Technologies, Inc. (NASDAQ:UFPT)

June 9, 2025 | marketbeat.com

Squarepoint Ops LLC Trims Position in UFP Technologies, Inc. (NASDAQ:UFPT)

June 8, 2025 | marketbeat.com

UFP Technologies Holds Annual Stockholders Meeting

June 6, 2025 | tipranks.com

Drug Development Inputs & Services Q1 Earnings: UFP Technologies (NASDAQ:UFPT) Simply the Best

June 4, 2025 | uk.finance.yahoo.com

UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the Goldman Sachs 46th Annual Global Healthcare Conference

June 4, 2025 | finance.yahoo.com

UFP Technologies to Present and Host 1x1 Investor Meetings at the 15th Annual East Coast IDEAS Investor Conference on June 11th in New York, NY

June 4, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Chime’s Smart IPO: Half the Valuation, Double the Strength
By Jeffrey Neal Johnson | June 18, 2025
View Chime’s Smart IPO: Half the Valuation, Double the Strength
Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker?
By Nathan Reiff | June 16, 2025
View Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker?
The Apple Comeback Will Be Better Than the Setback
By Gabriel Osorio-Mazilli | July 4, 2025
View The Apple Comeback Will Be Better Than the Setback
UPS Is Outpacing the Market: A Green Light for Investors?
By Jeffrey Neal Johnson | June 27, 2025
View UPS Is Outpacing the Market: A Green Light for Investors?
RH Stock Rockets on Surprise Profit and Tariff Shift
By Chris Markoch | June 15, 2025
View RH Stock Rockets on Surprise Profit and Tariff Shift

PROF, CTSO, UFPT, AFIB, and CLPT Company Descriptions

Acutus Medical NASDAQ:AFIB

$0.0001 0.00 (-95.00%)

As of 07/7/2025 12:48 PM Eastern

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

ClearPoint Neuro NASDAQ:CLPT

$11.76 -0.04 (-0.34%)

Closing price 04:00 PM Eastern

Extended Trading

$11.72 -0.04 (-0.38%)

As of 04:48 PM Eastern

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Cytosorbents NASDAQ:CTSO

$1.05 +0.02 (+1.94%)

Closing price 04:00 PM Eastern

Extended Trading

$1.05 0.00 (0.00%)

As of 05:34 PM Eastern

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

Profound Medical NASDAQ:PROF

$5.99 -0.10 (-1.64%)

As of 03:59 PM Eastern

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

UFP Technologies NASDAQ:UFPT

$243.12 +2.05 (+0.85%)

As of 04:00 PM Eastern

UFP Technologies, Inc. designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. It also provides molded composites for commercial aviation and military gear for use in backpack components, knee and elbow pads, eyewear, and helmets; and reusable cases and custom for applications in military ballistics panels, virtual training systems, drones, communications equipment, and rugged portable computers. In addition, the company provides engineered products and components to customers in the automotive, aerospace and defense, and industrial markets for applications in military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time